Berrettini W - Search Results

1

Pharmacogenetic approaches to the treatment of alcohol addiction.

Heilig M, Goldman D, Berrettini W, O'Brien CP. Heilig M, et al. Among authors: berrettini w. Nat Rev Neurosci. 2011 Oct 20;12(11):670-84. doi: 10.1038/nrn3110. Nat Rev Neurosci. 2011. PMID: 22011682 Free PMC article. Review.

2

Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.

Oslin DW, Leong SH, Lynch KG, Berrettini W, O'Brien CP, Gordon AJ, Rukstalis M. Oslin DW, et al. Among authors: berrettini w. JAMA Psychiatry. 2015 May;72(5):430-7. doi: 10.1001/jamapsychiatry.2014.3053. JAMA Psychiatry. 2015. PMID: 25760804 Clinical Trial.

3

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Clarke TK, Crist RC, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Ferraro TN, Lohoff FW, Berrettini WH. Clarke TK, et al. Among authors: berrettini wh. Neurosci Lett. 2013 May 10;542:71-5. doi: 10.1016/j.neulet.2013.02.018. Epub 2013 Feb 20. Neurosci Lett. 2013. PMID: 23454283 Free PMC article.

4

Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.

Oslin DW, Berrettini WH, O'Brien CP. Oslin DW, et al. Among authors: berrettini wh. Addict Biol. 2006 Sep;11(3-4):397-403. doi: 10.1111/j.1369-1600.2006.00036.x. Addict Biol. 2006. PMID: 16961767 Review.

5

Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence.

Lohoff FW, Bloch PJ, Ferraro TN, Berrettini WH, Pettinati HM, Dackis CA, O'Brien CP, Kampman KM, Oslin DW. Lohoff FW, et al. Among authors: berrettini wh. Neurosci Lett. 2009 Apr 10;453(3):199-203. doi: 10.1016/j.neulet.2009.02.026. Epub 2009 Feb 21. Neurosci Lett. 2009. PMID: 19429035 Free PMC article.

6

Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.

Munn-Chernoff MA, Johnson EC, Chou YL, Coleman JRI, Thornton LM, Walters RK, Yilmaz Z, Baker JH, Hübel C, Gordon S, Medland SE, Watson HJ, Gaspar HA, Bryois J, Hinney A, Leppä VM, Mattheisen M, Ripke S, Yao S, Giusti-Rodríguez P, Hanscombe KB, Adan RAH, Alfredsson L, Ando T, Andreassen OA, Berrettini WH, Boehm I, Boni C, Boraska Perica V, Buehren K, Burghardt R, Cassina M, Cichon S, Clementi M, Cone RD, Courtet P, Crow S, Crowley JJ, Danner UN, Davis OSP, de Zwaan M, Dedoussis G, Degortes D, DeSocio JE, Dick DM, Dikeos D, Dina C, Dmitrzak-Weglarz M, Docampo E, Duncan LE, Egberts K, Ehrlich S, Escaramís G, Esko T, Estivill X, Farmer A, Favaro A, Fernández-Aranda F, Fichter MM, Fischer K, Föcker M, Foretova L, Forstner AJ, Forzan M, Franklin CS, Gallinger S, Giegling I, Giuranna J, Gonidakis F, Gorwood P, Gratacos Mayora M, Guillaume S, Guo Y, Hakonarson H, Hatzikotoulas K, Hauser J, Hebebrand J, Helder SG, Herms S, Herpertz-Dahlmann B, Herzog W, Huckins LM, Hudson JI, Imgart H, Inoko H, Janout V, Jiménez-Murcia S, Julià A, Kalsi G, Kaminská D, Karhunen L, Karwautz A, Kas MJH, Kennedy JL, Keski-Rahkonen A, Kiezebrink K, Kim YR, Klump KL, Knudsen GPS, La Via MC, Le Hellard S, … See abstract for full author list ➔ Munn-Chernoff MA, et al. Among authors: berrettini wh. Addict Biol. 2021 Jan;26(1):e12880. doi: 10.1111/adb.12880. Epub 2020 Feb 16. Addict Biol. 2021. PMID: 32064741 Free PMC article.

7

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.

Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP. Oslin DW, et al. Among authors: berrettini w. Neuropsychopharmacology. 2003 Aug;28(8):1546-52. doi: 10.1038/sj.npp.1300219. Epub 2003 Jun 18. Neuropsychopharmacology. 2003. PMID: 12813472 Clinical Trial.

8

Association of multiple DRD2 polymorphisms with anorexia nervosa.

Bergen AW, Yeager M, Welch RA, Haque K, Ganjei JK, van den Bree MB, Mazzanti C, Nardi I, Fichter MM, Halmi KA, Kaplan AS, Strober M, Treasure J, Woodside DB, Bulik CM, Bacanu SA, Devlin B, Berrettini WH, Goldman D, Kaye WH. Bergen AW, et al. Among authors: berrettini wh. Neuropsychopharmacology. 2005 Sep;30(9):1703-10. doi: 10.1038/sj.npp.1300719. Neuropsychopharmacology. 2005. PMID: 15920508

9

Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence.

Lohoff FW, Bloch PJ, Weller AE, Nall AH, Doyle GA, Buono RJ, Ferraro TN, Kampman KM, Pettinati HM, Dackis CA, Oslin DW, O'Brien CP, Berrettini WH. Lohoff FW, et al. Among authors: berrettini wh. Neurosci Lett. 2008 Aug 8;440(3):280-3. doi: 10.1016/j.neulet.2008.05.073. Epub 2008 May 24. Neurosci Lett. 2008. PMID: 18572320 Free PMC article.

10

Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence.

Smith RJ, Doyle GA, Han AM, Crowley JJ, Oslin DW, Patkar AA, Mannelli P, Demaria PA Jr, O'brien CP, Berrettini WH. Smith RJ, et al. Among authors: berrettini wh. Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):105-9. doi: 10.1002/ajmg.b.30105. Am J Med Genet B Neuropsychiatr Genet. 2005. PMID: 15558714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

463 results

Search Page